Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
Search Article 
Advanced search 
  Users Online: 878 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

Table of Contents
Year : 2014  |  Volume : 18  |  Issue : 6  |  Page : 872

Screening for diabetes in high risk a passé

1 Department of Endocrinology, Synergy Hospital, Indore, Madya Pradesh, India
2 Department of Dietetics, Synergy Hospital, Indore, Madya Pradesh, India

Date of Web Publication20-Sep-2014

Correspondence Address:
Dr. Sandeep Julka
Scheme No. 74c, Sector B, Vijay Nagar, Indore - 452 001, Madya Pradesh
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/2230-8210.141393

Rights and Permissions

How to cite this article:
Julka S, Goyal R, Sharma R. Screening for diabetes in high risk a passé. Indian J Endocr Metab 2014;18:872

How to cite this URL:
Julka S, Goyal R, Sharma R. Screening for diabetes in high risk a passé. Indian J Endocr Metab [serial online] 2014 [cited 2021 Feb 27];18:872. Available from: https://www.ijem.in/text.asp?2014/18/6/872/141393


Approximately, 50-70% of people with diabetes remain undiagnosed in both developed [1] and developing countries [2] and these individuals often present with diabetes complications. [3] Undiagnosed diabetes and pre diabetes, therefore, need to be detected and treated early through community-based screening. [4] Unless appropriate action is taken, it is predicted that there will be at least 592 million people in the world with type 2 diabetes by the year 2035. Indeed, India with 65.1 million people with diabetes leads the world with the maximum number in any country, and this number is set to increase by the year 2025. [5]

Early detection significance considering that diabetes is frequently not diagnosed until complications appear, and approximately half of all subjects with diabetes remain undiagnosed. [6],[7]

Definition of diabetes is usually based on fasting or postprandial glucose. However, random capillary blood glucose (RCBG) is the most convenient way to reach large number of people. [8]

To cost-effectively screen for diabetes at the community level, involves the use of blood test, such as RCBG to further narrow down for individuals with undiagnosed diabetes.

To the same context, an RCBG checkup camp was organized on world labor day (May 1, 2014) for the daily wedges worker by our institute in Indore, irrespective of their age and gender. Approximately, 870 individuals underwent an RCBG test using one touch ultra (Accu check, Abbott and Johnson and Johnson). Our teams were deployed at their respective site of gathering, from where they are picked up for daily jobs.

After the statistical analysis we found that 24% (213) people had random blood sugar (RBS) >110 mg/dl, out of them 9% (78) people had RBS between 140 and 199 mg/dl and 3.5% (31) had RBS > 200 mg/dl.

In a paper published in diabetes care Somannavar et al. propose an RCBG value of >110 mg/dl should receive more definitive tests for diabetes and prediabetes. [8]

This underscores the need for mass awareness and screening program to detect undiagnosed diabetes and thus reduce the burden of diabetes in India. Mass screening program using blood sugar estimations to cover the whole population are not feasible in a large country like ours with a population of over 1 billion people due to logistic, socioeconomic and other constraints. Hence, cost-effective tools to selectively screen population, which may often see low risk for diabetes are urgently needed in order to make diabetes screening cost-effective in India.

   References Top

1.Harris MI. Undiagnosed NIDDM: Clinical and public health issues. Diabetes Care 1993;16:642-52.  Back to cited text no. 1
2.Mohan V, Deepa M, Deepa R, Shanthirani CS, Farooq S, Ganesan A, et al. Secular trends in the prevalence of diabetes and impaired glucose tolerance in urban South India - The Chennai Urban Rural Epidemiology Study (CURES-17). Diabetologia 2006;49:1175-8.  Back to cited text no. 2
3.Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 1992;15:815-9.  Back to cited text no. 3
4.American Diabetes Association. Screening for type 2 diabetes (Position Statement). Diabetes Care 2004;27:S11-4.  Back to cited text no. 4
5.IDF. Diabetes Atlas. 6 th ed. http://www.idf.org/worlddiabetesday/toolkit/gp/facts-figures. International Diabetes Federation; 2013.   Back to cited text no. 5
6.Harris MI, Eastman RC. Early detection of undiagnosed diabetes mellitus: A US perspective. Diabetes Metab Res Rev 2000;16:230-6.  Back to cited text no. 6
7.Mohan D, Raj D, Shanthirani CS, Datta M, Unwin NC, Kapur A, et al. Awareness and knowledge of diabetes in Chennai - The Chennai Urban Rural Epidemiology Study [CURES-9]. J Assoc Physicians India 2005;53:283-7.  Back to cited text no. 7
8.Somannavar S, Ganesan A, Deepa M, Datta M, Mohan V. Random capillary blood glucose cut points for diabetes and pre-diabetes derived from community-based opportunistic screening in India. Diabetes Care 2009;32:641-3.  Back to cited text no. 8


    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

  In this article

 Article Access Statistics
    PDF Downloaded207    
    Comments [Add]    

Recommend this journal